bioMérieux S.A. (FRA:EYWN)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Clinical Applications	3.37B	3.10B	3.04B	2.88B	2.66B
Clinical Applications Growth	8.85%	1.95%	5.43%	8.26%	20.62%
Industrial Applications	606.00M	575.30M	549.00M	492.60M	454.60M
Industrial Applications Growth	5.34%	4.79%	11.45%	8.36%	-2.57%
Other	-	-	-	200.00K	-
Total	3.98B	3.67B	3.59B	3.38B	3.12B
Total Growth	8.30%	2.38%	6.31%	8.28%	16.57%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Asia-Pacific (ASPAC)	656.20M	637.70M	624.30M	580.60M	504.60M
Asia-Pacific (ASPAC) Growth	2.90%	2.15%	7.53%	15.06%	-1.77%
Americas	2.05B	1.85B	1.84B	1.67B	1.59B
Americas Growth	11.29%	0.26%	10.32%	5.08%	32.44%
France	240.10M	225.50M	-	222.30M	218.80M
France Growth	6.47%	-	-	1.60%	10.62%
Corporate	600.00K	900.00K	2.60M	2.80M	3.50M
Corporate Growth	-33.33%	-65.38%	-7.14%	-20.00%	-23.91%
Europe, The Middle East and Africa (EMEA) Excluding France	1.03B	964.80M	-	901.60M	803.10M
Europe, The Middle East and Africa (EMEA) Excluding France Growth	6.63%	-	-	12.26%	5.74%
Europe, The Middle East and Africa (EMEA)	-	-	1.12B	-	-
Total	3.98B	3.67B	3.59B	3.38B	3.12B
Total Growth	8.31%	2.39%	6.30%	8.27%	16.58%

Source: S&P Global Market Intelligence.